Researchers revved up immune cells that shrank an extremely aggressive type of brain tumor when tested in a handful of patients. The experiments are just first steps but they signal a new strategy to fight hard-to-treat glioblastoma. It's a twist on the CAR-T therapy already used to treat leukemia, by modifying patients' own disease-fighting T cells to be better cancer hunters. Now Massachusetts General Hospital and the University of Pennsylvania are trying next-generation versions strengthened to try to overcome glioblastoma's stronger defenses. Early findings were published Wednesday in the New England Journal of Medicine and Nature Medicine.
Hence then, the article about a new strategy to attack aggressive brain cancer shrank tumors in two early tests was published today ( ) and is available onChron ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( A new strategy to attack aggressive brain cancer shrank tumors in two early tests )